Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|November 1, 1994
Deferiprone-associated myelotoxicityF N al-Refaie, B Wonke, A V Hoffbrand
Journal of Clinical Pathology|August 1, 1990
Antibody to hepatitis C virus in multiply transfused patients with thalassaemia majorB Wonke, A V Hoffbrand, D Brown, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|March 26, 1999
Pregnancy management and outcomes in women with thalassaemia majorS M Tuck, C E Jensen, B Wonke, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 17, 2007
Microcytosis, iron deficiency and thalassaemia in a multi-ethnic community: a pilot studyB Wonke, M Modell, T Marlow, et al.
The British Journal of Ophthalmology|December 1, 1984
Ocular changes in patients undergoing long-term desferrioxamine treatmentG B Arden, B Wonke, C Kennedy, et al.
British Journal of Haematology|May 1, 1994
The effect of deferiprone (L1) and desferrioxamine on myelopoiesis using a liquid culture systemF N al-Rafaie, S Wilkes, B Wonke, et al.
Annals of the New York Academy of Sciences|July 21, 1998
New approaches to the management of hepatitis and endocrine disorders in Cooley's anemiaB Wonke, A V Hoffbrand, P Bouloux, et al.
Archives of Disease in Childhood|April 1, 1989
Intradermal hepatitis B vaccine in thalassaemia and sickle cell diseaseQ Mok, G Underhill, B Wonke, et al.
Archives of Disease in Childhood|May 1, 1995
Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosisS Ratip, D Skuse, J Porter, et al.
Pageof 7